Drug Screening Market Trends

  • Report ID: 4891
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Drug Screening Market Trends

  • Stringent Government Regulations: The government regulations mandating drug screening in various settings such as schools, and sports organizations are driving the growth of the market. For instance, the US Department of Transportation (DOT) mandates drug testing for safety-sensitive transportation industries, including aviation, trucking, and railroads.
  • Increasing Demand for Workplace Drug Testing: The growing demand for drug testing in the workplace is one of the major factors that is contributing to the demand for drug screening.
  • Rise in Research Spending – There has been an increased investment in research and development activities to continuously find more viable solutions for drug screening.
  • Growing Awareness About Drug Testing Equipment: The increasing awareness about the benefits of drug testing, and its equipment for promoting public health and safety is driving the growth of the industry. For instance, drug testing is widely used in healthcare settings in order to monitor patients who are on prescription opioids to prevent drug misuse and addiction.

Challenges

  • Legal and Ethical Issues: Drug screening raises a range of legal and ethical issues, including questions about privacy, discrimination, and false positives/negatives. Employers and other organizations must navigate these issues carefully to avoid legal liability and maintain the trust of employees and other stakeholders.
  • Variability in Drug Test Results
  • Lack of Standardization

Drug Screening Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

19.6%

Base Year Market Size (2024)

USD 9.99 billion

Forecast Year Market Size (2037)

USD 105.01 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4891
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of drug screening is estimated at USD 11.57 billion.

The drug screening market size was over USD 9.99 billion in 2024 and is projected to cross USD 105.01 billion by the end of 2037, growing at more than 19.6% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of drug abuse, and stringent government regulations will boost the market growth.

Asia Pacific industry is set to hold 24% of the revenue share till 2037, impelled by rising awareness about drug screening in the region.

The major players in the market include Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), Thermo Fisher Scientific, Alere Inc., Siemens Healthineers, Shimadzu Corporation, F. Hoffmann-La Roche AG, Express Diagnostics International Inc., OraSure Technologies, Drägerwerk AG & Co. KGaA.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample